Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 321.70
-10.30 (-3.10%)
Oct 7, 2026, 3:29 PM IST
Suraksha Diagnostic Market Cap
Suraksha Diagnostic has a market cap or net worth of 16.75 billion as of October 7, 2026. That makes Suraksha Diagnostic the world's 21,882nd most valuable company and 1,355th in India. Its market cap has increased by 6.61% in one year.
Market Cap
16.75B
Enterprise Value
17.78B
Revenue
3.25B
Global Rank
Country Rank
#1,355 India
PE Ratio
46.77
ChartMarket Cap Chart
Since December 6, 2024, Suraksha Diagnostic's market cap has decreased from 21.73B to 16.75B, a decrease of -22.90%. That is a compound annual growth rate of -13.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 16.75B | 19.30% |
| Dec 31, 2025 | 14.04B | -28.22% |
| Dec 31, 2024 | 19.56B | -9.97% |
| Dec 6, 2024 | 21.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 2.46T |
| Lenskart Solutions | 1.20T |
| Apollo Hospitals Enterprise | 1.15T |
| Panacea Biotec | 21.45B |
| Windlas Biotech | 21.01B |
| Beta Drugs | 20.31B |
| Krsnaa Diagnostics | 18.14B |